STAT June 20, 2024
Annalisa Merelli

Gestational diabetes affects one in seven expecting women globally and rates of this troubling condition are rising. Blood glucose levels that become elevated for the first time during pregnancy can lead to severe complications, such as preeclampsia, and increase the risk of stillbirth. And while the condition typically resolves after birth, it is linked to a tenfold increase in the risk of developing type 2 diabetes, along with risks for the child including obesity, cardiovascular disease, and neurodevelopmental disorders.

Gestational diabetes has long been diagnosed between weeks 24 and 28 of pregnancy. But a recent randomized control study called Treatment of Booking Gestational Diabetes Mellitus, or TOBOGM, which was started in 2018 and whose results were published earlier this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Patient / Consumer, Provider, Trends
AI tool helps find life-saving medicine for rare disease
Radiology business advocates’ top 5 priorities in Washington
Employers Reap $190 for Every $100 Invested in Behavioral Health
Calling patients at their home
Affineon Health Raises $5M for AI-Powered Physician Inbox Management

Share This Article